Building on strength
Hypercoagulation and thrombophilia in liver disease
Unresolved roles of platelet nitric oxide synthase
Clinical and genetic correlates of soluble P-selectin in the community
Activation of coagulation with concurrent impairment of anticoagulant mechanisms correlates with a poor outcome in severe melioidosis
Comparison of the revised Geneva score with the Wells rule for assessing clinical probability of pulmonary embolism
Variation in 24 hemostatic genes and associations with non-fatal myocardial infarction and ischemic stroke
The Residual Platelet Aggregation after Deployment of Intracoronary Stent (PREDICT) score
ABO(H) blood groups and vascular disease
Association between inherited thrombophilic abnormalities and central venous catheter thrombosis in patients with cancer
Defining the structure of membrane-bound human blood coagulation factor Va
Proposed structural models of human factor Va and prothrombinase
The effect of exercise on von Willebrand factor and ADAMTS-13 in individuals with type 1 and type 2B von Willebrand disease
von Willebrand factor
Thrombin generation in acute coronary syndrome and stable coronary artery disease
Combined tissue factor pathway inhibitor and thrombomodulin deficiency produces an augmented hypercoagulable state with tissue-specific fibrin deposition
The contribution of amino acid residues 1508–1515 of factor V to light chain generation
Coagulation factors and the protein C system as determinants of thrombin generation in a normal population
Development of sandwich-type ELISAs for the quantification of rat and murine thrombin activatable fibrinolysis inhibitor in plasma
Protective role of thrombin activatable fibrinolysis inhibitor in obstructive nephropathy-associated tubulointerstitial fibrosis
Fibrinolysis in patients with an abdominal aortic aneurysm with special emphasis on rupture and shock
Development of a new test for the global fibrinolytic capacity in whole blood
Modulation of immune response with cytotoxic T-lymphocyte-associated antigen 4 immunoglobulin-induced anergic T cells in chronic idiopathic thrombocytopenic purpura2
Pyrazolinone analgesics prevent the antiplatelet effect of aspirin and preserve human platelet thromboxane synthesis1
Networking with fibrinogen
Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2)
Homocysteine induces connective tissue growth factor expression in vascular smooth muscle cells
Characterization of a causative mutation of hemophilia A identified in the promoter region of the factor VIII gene (F8)
Inflammation triggers colony forming endothelial cell mobilization after angioplasty in chronic lower limb ischemia
Heparin-independent activation of platelets by heparin-induced thrombocytopenia antibodies
Carboxypeptidase U (TAFIa) activity is induced in vivo in ischemic stroke patients receiving thrombolytic therapy
Prevalence of the JAK2 V617F mutation is low among unselected patients with a first episode of unprovoked venous thromboembolism
In support of the revised World Health Organization diagnostic criteria for essential thrombocythemia
Pharmacogenetic dose refinement prevents warfarin overdose in a patient who is highly warfarin-sensitive
Reassessment of in vivo thrombus formation in glycoprotein V deficient mice backcrossed on a C57Bl/6 strain
Inherited and de novo mutations of ADAMTS13 in a patient with Upshaw-Schulman syndrome
Sandor S. Shapiro